M. A. Caligiuri - Concepedia

Author

M. A. Caligiuri

Also Known As

Der, C. J., M A Caligiuri, M CALIGIURI, M Caligiuri, M. A. Caligiuri, M. Caligiuri, M.A. Caligiuri, Michael A. Caligiuri, Michael A. Caligiuri

Publications

14.1K

Citations

H-Index

Concepts

All Affiliations

The Ohio State University Roswell Park Comprehensive Cancer Center Cancer Genetics (United States)Thomas Jefferson University Jefferson Institute

About

M. A. Caligiuri is an author at The Ohio State University specializing in medicine, cell biology, and genetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	13.9K
2	Health Sciences	3	3	635
3	Natural Sciences	2	2	203
4	Engineering	1	1	11.6K
5	Biostatistics	1	1	11.6K

M. A. Caligiuri

Publications

14K

Citations

H-Index

Page 1

	Year	Citations
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring Todd R. Golub, Donna K. Slonim, Pablo Tamayo, Science EngineeringMixed-phenotype Acute LeukemiaDna MicroarraysPathologyClass Discovery	1999	11.6K
Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. Susan P. Whitman, Kellie J. Archer, Feng Lin, PubMed Hematological MalignancyFlt3 GeneMedicineGeneticsAcute Myeloid Leukemia	2001	638
Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. William E. Carson, M. Elizabeth Ross, Robert A. Baiocchi, Journal of Clinical Investigation Innate Immune SystemImmune RegulationImmunologyNk CellsImmunologic Mechanism	1995	353
Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. M. A. Caligiuri, Matthew P. Strout, David Lawrence, PubMed Hematological MalignancyChromatinAll1 RearrangementMixed-phenotype Acute LeukemiaGenetics	1998	229
ALL-1 partial duplication in acute leukemia. Steven A. Schichman, M. A. Caligiuri, Yusu Gu, Proceedings of the National Academy of Sciences Normal KaryotypeChromatinPartial DuplicationHematological MalignancyCytogenetics	1994	214
Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11. M. A. Caligiuri, Matthew P. Strout, Steven A. Schichman, PubMed CytogeneticsMixed-phenotype Acute LeukemiaGeneticsPathologyEpigenetics	1996	192
ALL-1 tandem duplication in acute myeloid leukemia with a normal karyotype involves homologous recombination between Alu elements. Steven A. Schichman, M. A. Caligiuri, Matthew P. Strout, PubMed CytogeneticsMixed-phenotype Acute LeukemiaGeneticsMolecular BiologyMolecular Genetics	1994	167
Receptor tyrosine kinase Axl is required for resistance of leukemic cells to FLT3-targeted therapy in acute myeloid leukemia I-K Park, Bethany L. Mundy-Bosse, Susan P. Whitman, Leukemia Hematological MalignancyTumor BiologyLeukemic CellsMixed-phenotype Acute LeukemiaAcute Myeloid Leukemia	2015	159
The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2. William E. Carson, Subrata Haldar, Robert A. Baiocchi, Proceedings of the National Academy of Sciences Radiation OncologyNatural Killer CellsCd56bright Nk CellsMedicineHuman Natural Killer	1994	147
Interleukin-1β costimulates interferon-γ production by human natural killer cells Megan A. Cooper, Todd A. Fehniger, Anand Ponnappan, European Journal of Immunology Innate Immune SystemImmune RegulationImmunologyNk CellsImmunologic Mechanism	2001	119

Page 1